PL4068993T3 - Mieszanka dla niemowląt o specjalnej strukturze lipidowej poprawiająca wzrost po narodzinach niemowląt urodzonych przez matki z nadwagą i otyłością - Google Patents

Mieszanka dla niemowląt o specjalnej strukturze lipidowej poprawiająca wzrost po narodzinach niemowląt urodzonych przez matki z nadwagą i otyłością

Info

Publication number
PL4068993T3
PL4068993T3 PL20816247.9T PL20816247T PL4068993T3 PL 4068993 T3 PL4068993 T3 PL 4068993T3 PL 20816247 T PL20816247 T PL 20816247T PL 4068993 T3 PL4068993 T3 PL 4068993T3
Authority
PL
Poland
Prior art keywords
overweight
infant formula
infants born
postnatal growth
special lipid
Prior art date
Application number
PL20816247.9T
Other languages
English (en)
Inventor
Stefanie SCHOEN
Dennis Stanley ACTON
Original Assignee
N.V. Nutricia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=68806669&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL4068993(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Nutricia filed Critical N.V. Nutricia
Publication of PL4068993T3 publication Critical patent/PL4068993T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL20816247.9T 2019-12-05 2020-12-04 Mieszanka dla niemowląt o specjalnej strukturze lipidowej poprawiająca wzrost po narodzinach niemowląt urodzonych przez matki z nadwagą i otyłością PL4068993T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19213823 2019-12-05
PCT/EP2020/084632 WO2021110916A1 (en) 2019-12-05 2020-12-04 Infant formula with special lipid architecture for improving postnatal growth of infants born to overweight and obese mothers

Publications (1)

Publication Number Publication Date
PL4068993T3 true PL4068993T3 (pl) 2024-06-24

Family

ID=68806669

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20816247.9T PL4068993T3 (pl) 2019-12-05 2020-12-04 Mieszanka dla niemowląt o specjalnej strukturze lipidowej poprawiająca wzrost po narodzinach niemowląt urodzonych przez matki z nadwagą i otyłością

Country Status (8)

Country Link
US (1) US20220386672A1 (pl)
EP (1) EP4068993B1 (pl)
CN (1) CN114745969A (pl)
AU (1) AU2020396275C1 (pl)
BR (1) BR112022010229A2 (pl)
ES (1) ES2984454T3 (pl)
PL (1) PL4068993T3 (pl)
WO (1) WO2021110916A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4346447A1 (en) 2021-05-26 2024-04-10 N.V. Nutricia Infant formula for improving body composition development
EP4346448A1 (en) 2021-05-26 2024-04-10 N.V. Nutricia Infant formula comprising milk fat for reducing the risk of obesity in at risk infants

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601860A (en) 1990-11-30 1997-02-11 American Home Products Corporation Corandomized fat compositions for infant formulas
ES2105712T3 (es) 1993-05-13 1997-10-16 Loders Croklaan Bv Sustitutivos de grasa de leche humana a partir de mezclas interesterificadas de trigliceridos.
EP1932437A1 (en) * 2006-12-15 2008-06-18 Nestec S.A. Infant formula
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP2346355B1 (en) 2008-09-02 2019-12-04 N.V. Nutricia Nutritional compositions with large diameter lipid globules with a coating comprising polar lipids
WO2011108918A1 (en) 2010-03-04 2011-09-09 N.V. Nutricia Modulation of post-prandial fat absorption
WO2012173467A1 (en) * 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
EP2638811A1 (en) 2012-03-15 2013-09-18 N.V. Nutricia Process for preparing infant formula
WO2014058301A1 (en) * 2012-10-12 2014-04-17 N.V. Nutricia Infant nutrition with lipid globules to increase energy expenditure and metabolic flexibility later in life
EP3091973B1 (en) 2013-11-01 2018-08-15 N.V. Nutricia Lipid composition for improving body composition during catch-up growth
CN105813475A (zh) * 2013-12-12 2016-07-27 雀巢产品技术援助有限公司 特别适合于男女婴儿和幼儿的合成营养组合物
DK3361885T3 (da) * 2015-10-15 2019-07-29 Nutricia Nv Modermælkserstatning med særlig lipidarkitektur til fremme af sund vækst
EP3362061B1 (en) 2015-10-15 2023-09-06 N.V. Nutricia Infant formula with milk fat for promoting healthy growth
RU2761065C2 (ru) * 2017-03-29 2021-12-02 Н.В. Нютрисиа Детская смесь для улучшения пищевого поведения
EP4061152B1 (en) 2019-11-22 2023-11-01 N.V. Nutricia Infant formula for reducing the risk of developing non-alcoholic fatty liver disease

Also Published As

Publication number Publication date
EP4068993A1 (en) 2022-10-12
EP4068993B1 (en) 2024-02-14
US20220386672A1 (en) 2022-12-08
AU2020396275A1 (en) 2022-06-02
ES2984454T3 (es) 2024-10-29
BR112022010229A2 (pt) 2022-09-06
WO2021110916A1 (en) 2021-06-10
AU2020396275B2 (en) 2022-09-01
AU2020396275C1 (en) 2023-02-16
CN114745969A (zh) 2022-07-12

Similar Documents

Publication Publication Date Title
PL4068993T3 (pl) Mieszanka dla niemowląt o specjalnej strukturze lipidowej poprawiająca wzrost po narodzinach niemowląt urodzonych przez matki z nadwagą i otyłością
IN2012DN01511A (pl)
PH12017500874A1 (en) Human milk oligosaccharides for modulating inflammation
BR112015023011A2 (pt) fórmula para bebês contendo baixa caloria
MY196432A (en) Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
PH12016500846B1 (en) Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by c-section
PL2585085T3 (pl) Zastosowanie Lactobacilli hamujących wytwarzające gaz gram-ujemne pałeczki jelitowe izolowane od niemowląt z kolką
PH12013501358A1 (en) Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MY182925A (en) Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
MY161386A (en) Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof
PH12013501360A1 (en) Nutritional products including a novel fat system including monoglycerides
RU2014150662A (ru) Диетотерапия целиакии и пищевой аллергии
PH12015502194A1 (en) Infant formula with a low content of medium-chain fatty acids in specific proportions, and its use in promoting and/or ensuring a balanced growth in infants
MX347403B (es) Composiciones anti-regurgitacion y/o anti-reflujo gastroesofagico, preparacion y usos.
PH12018501150A1 (en) Nutritional compositions and infant formulas containing relatively high level of oligofructose for inducing gut microbiota patterns close to those of human milk fed infants
PL4068991T3 (pl) Mieszanka do żywienia niemowląt, o specjalnej strukturze lipidowej, poprawiająca wzrost niemowląt, po narodzinach urodzonych przez cesarskie cięcie
PL4346450T3 (pl) Preparat do początkowego żywienia niemowląt do żywienia niemowląt otrzymujących preparat do początkowego żywienia niemowląt i mleko kobiece
PT2532282E (pt) Berço/cama para bebé e/ou criança pequena
PH12015502130A1 (en) Low calorie infant formula containing beta - hydroxy - beta - methylbutyric acid to promote protein synthesis and accretion of lean body mass in term infants
DK2663366T3 (da) Aminosyresammensætning og anvendelse deraf til behandling af intrauterin fostervæksthæmning (iugr) eller til parenteral ernæring af meget for tidligt fødte
CN201719561U (zh) 设置温度计的奶瓶
Shamir et al. Re: ESPGHAN's 2008 recommendation for early introduction of complementary foods: how good is the evidence?(Cattaneo et al. 2011)
RU2014142007A (ru) Добавление лактоферрина и диарея
Fierman Infants born between 34 0/7 and 36 6/7 weeks of gestational age (so-called late preterm infants) present some challenges to the clinician and to both hospital and public health systems. Foreword